Clinical Trials Logo

Filter by:
NCT ID: NCT00360945 Active, not recruiting - Clinical trials for Brain and Central Nervous System Tumors

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Start date: April 2004
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as cisplatin and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving cisplatin together with temozolomide works in treating young patients with malignant glioma.

NCT ID: NCT00360854 Active, not recruiting - Clinical trials for Brain and Central Nervous System Tumors

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Start date: May 2005
Phase: Phase 1
Study type: Interventional

RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving erlotinib together with radiation therapy may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of erlotinib when given alone or together with radiation therapy in treating young patients with refractory or relapsed malignant brain tumors or newly diagnosed brain stem glioma.

NCT ID: NCT00359762 Completed - Clinical trials for Type 2 Diabetes Mellitus

Exenatide Versus Glimepiride in Patients With Type 2 Diabetes

Start date: September 2006
Phase: Phase 3
Study type: Interventional

This study assesses the effects of twice-daily subcutaneous injection exenatide versus treatment with sulfonylurea (glimepiride) on long-term glycemic control and beta-cell function.

NCT ID: NCT00359112 Completed - Clinical trials for Non-Insulin-Dependent Diabetes Mellitus

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

Start date: February 2004
Phase: Phase 3
Study type: Interventional

This study compares the effects of Avandamet (rosiglitazone maleate/metformin) treatment and metformin plus sulphonylurea treatment in overweight people with type 2 diabetes.

NCT ID: NCT00358566 Terminated - Clinical trials for Advanced Unresectable Pancreatic Cancer

GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer

Start date: June 2006
Phase: Phase 3
Study type: Interventional

To investigate the efficacy of GV1001 in sequential combination with gemcitabine in locally advanced and metastatic adenocarcinoma of the pancreas.

NCT ID: NCT00356421 Terminated - Clinical trials for Diabetes Mellitus, Type 1

A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

Start date: November 2006
Phase: Phase 4
Study type: Interventional

To compare efficacy and safety of Exubera® vs Humalog in patients with type 1 diabetes mellitus

NCT ID: NCT00356096 Completed - Depression Clinical Trials

Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances

Start date: July 2006
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to determine the efficacy of pramipexole 0.125 mg to 0.75 mg daily versus placebo on RLS symptoms and on associated mood disturbances and depressive symptoms, after 12 weeks of treatment

NCT ID: NCT00355901 Terminated - Ulcerative Colitis Clinical Trials

An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis

Start date: September 2006
Phase: Phase 2
Study type: Observational

To assess the effects of visilizumab on the safety of subsequent salvage therapies in subjects who experienced disease progression in a previous visilizumab study and subsequently received salvage therapy.

NCT ID: NCT00354562 Terminated - Lung Cancer Clinical Trials

A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer

Start date: February 2007
Phase: Phase 1/Phase 2
Study type: Interventional

To determine the efficacy of ABT-751 when administered in combination with standard docetaxel in subjects with advanced or metastatic NSCLC.

NCT ID: NCT00349531 Completed - Clinical trials for Restless Legs Syndrome

A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

Start date: July 2006
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to investigate the effects on RLS symptoms and sleep disturbance of pramipexole (Mirapexin) 0.125 mg/day to 0.75 mg/day per os for 12 weeks, compared to placebo, in the treatment of patients with idiopathic Restless Legs Syndrome